
AIDX P/E Ratio
P/E Ratio as of Mar 12, 2026: 5.39
Average13.17
Median7.31
Minimum5.39
Maximum51.85
5.39
The P/E ratio for AIDX is 5.39 as of Mar 12, 2026. This represents a increase of 9.11% compared to its 12-month average P/E ratio of 4.94. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.
20/20 Biolabs Inc P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
20/20 Biolabs Inc’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing 20/20 Biolabs Inc to industry peers.
20/20 Biolabs Inc P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
20/20 Biolabs Inc’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing 20/20 Biolabs Inc to industry peers.
AIDX P/E Ratio Insights
See 20/20 Biolabs Inc’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in AIDX
Order type
Buy in
Order amount
Est. shares
0 shares
AIDX P/E Ratio Historic Data
| Date | Stock price | P/E ratio |
|---|
AIDX End of Year P/E Ratio
| Date | P/E ratio | Change |
|---|---|---|
| 2026 | 5.39 | — |
FAQs About 20/20 Biolabs Inc (AIDX) P/E ratio
The latest P/E ratio of AIDX is 5.39, as of Mar 12, 2026. This is calculated based on its current stock price and earnings per share (EPS).
20/20 Biolabs Inc’s last 12-month average P/E ratio is 4.94, compared to its current P/E ratio of 5.39. This reflects a increase of 9.11%.
20/20 Biolabs Inc’s current P/E ratio of 5.39 is higher than its last 12-month average P/E of 4.94. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.
20/20 Biolabs Inc’s average P/E ratio over the last 3 years is 1.65. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.
20/20 Biolabs Inc’s average P/E ratio over the last 5 years is 0.99. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.